Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma

Rodolfo Montironi, Alessia Cimadamore, Silvia Gasparrini, Roberta Mazzucchelli, Matteo Santoni, Francesco Massari, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli

Research output: Contribution to journalReview article

5 Scopus citations


Introduction: The Gleason grading system is one of the most important prognostic factors in prostate cancer (PCa). From the 2005 to the 2014 conference organized by the International Society of Urological Pathology (ISUP), the histological criteria for the Gleason patterns were improved, resulting in the shrinkage of the Gleason pattern (GP) 3 and expansion of the GP 4. Areas Covered: Cribriform, fused, ill-defined and glomeruloid glands are part of the morphologic spectrum of the current GP 4. Cribriform, derived from the Latin word cribrum (i.e. sieve), was introduced by Gleason to describe glands composed of a solid sheet with perforations or lumina. Cribriform morphology has a worse prognosis compared with the other, non-cribriform, GP4 morphologies. A practical implication is that a cribriform growth precludes a patient from selecting an active surveillance (AS) protocol. Expert commentary: The presence of these four growth patterns should be incorporated into the current Grade Group (GG) system. Enhancing our understanding of cribriform tumor behavior will lead to correctly identifying and treating those patients that will die because of PCa, while sparing treatment in those who do not require it.

Original languageEnglish (US)
Pages (from-to)685-693
Number of pages9
JournalExpert Review of Anticancer Therapy
Issue number7
StatePublished - Jul 3 2018



  • cribriform morphology
  • gleason
  • Gleason grading
  • Gleason pattern 4
  • intraductal carcinoma
  • Prostate cancer

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this